Rhumbline Advisers Bio Xcel Therapeutics, Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 11,502 shares of BTAI stock, worth $6,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,502

Previous 29,685 61.25%

Holding current value

$6,326

Previous $83,000 83.13%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$1.14 - $2.97 $20,728 - $54,003	-18,183 Reduced 61.25%	11,502 $14,000
Q1 2024 May 09, 2024	BUY	$1.95 - $4.04 $1,366 - $2,832	701 Added 2.42%	29,685 $83,000
Q4 2023 Feb 08, 2024	BUY	$2.32 - $5.51 $3,691 - $8,766	1,591 Added 5.81%	28,984 $85,000
Q3 2023 Nov 09, 2023	SELL	$2.49 - $11.85 $2,151 - $10,238	-864 Reduced 3.06%	27,393 $69,000
Q2 2023 Aug 08, 2023	SELL	$6.39 - $28.58 $33,438 - $149,559	-5,233 Reduced 15.63%	28,257 $188,000
Q1 2023 May 11, 2023	BUY	$17.7 - $33.24 $46,657 - $87,620	2,636 Added 8.54%	33,490 $625,000
Q4 2022 Feb 14, 2023	BUY	$10.25 - $22.43 $5,135 - $11,237	501 Added 1.65%	30,854 $663,000
Q3 2022 Nov 10, 2022	BUY	$11.19 - $17.89 $20,611 - $32,953	1,842 Added 6.46%	30,353 $359,000
Q2 2022 Aug 11, 2022	BUY	$9.03 - $21.55 $93,054 - $222,072	10,305 Added 56.6%	28,511 $376,000
Q1 2022 May 12, 2022	BUY	$15.0 - $22.83 $31,560 - $48,034	2,104 Added 13.07%	18,206 $381,000
Q4 2021 Feb 10, 2022	BUY	$20.12 - $35.09 $15,894 - $27,721	790 Added 5.16%	16,102 $327,000
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $19,405 - $26,072	814 Added 5.61%	15,312 $465,000
Q2 2021 Aug 05, 2021	BUY	$29.06 - $38.83 $26,822 - $35,840	923 Added 6.8%	14,498 $421,000
Q1 2021 May 06, 2021	SELL	$39.04 - $64.6 $64,611 - $106,912	-1,655 Reduced 10.87%	13,575 $586,000
Q4 2020 Feb 10, 2021	BUY	$42.46 - $56.58 $59,953 - $79,890	1,412 Added 10.22%	15,230 $704,000
Q3 2020 Nov 12, 2020	SELL	$37.44 - $64.63 $61,588 - $106,316	-1,645 Reduced 10.64%	13,818 $599,000
Q2 2020 Aug 13, 2020	BUY	$17.62 - $58.71 $272,458 - $907,832	15,463 New	15,463 $820,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

7.26M

Call Options Held

101K

Put Options Held

205K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $15.4M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Bio Xcel Therapeutics, Inc. Transaction History